AMICUS THERAPEUTICS, INC. — Director's Dealing 2012

Jul 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-07-09

Reporting Person: ESSNER ROBERT (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-09	Stock Option (right to buy)	$6.14	A	30000	Acquired	2022-07-09	Common Stock (30000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on July 9, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on August 1, 2013, with the final installment vesting on July 9, 2016.